TY - JOUR T1 - Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study. AU - Lai,Jung-Nien, AU - Wu,Chien-Tung, AU - Wang,Jung-Der, Y1 - 2012/05/28/ PY - 2012/01/04/received PY - 2012/03/13/revised PY - 2012/03/27/accepted PY - 2012/6/12/entrez PY - 2012/6/12/pubmed PY - 2012/6/12/medline SP - 891893 EP - 891893 JF - Evidence-based complementary and alternative medicine : eCAM JO - Evid Based Complement Alternat Med VL - 2012 N2 - Background. Chinese herbal products (CHPs) given as a therapy for symptom relief have gained widespread popularity among women with breast cancer. The aim of this study was to analyze the utilization of CHP among women with breast cancer in Taiwan. Methods. The usage, frequency of services, and CHP prescribed for breast cancer among women with breast cancer were evaluated, recruited from a randomly sampled cohort of 1,000,000 beneficiaries from the National Health Insurance Research Database. The logistic regression method was employed to estimate the odds ratios (ORs) for utilization of CHP. Results. 81.5 percent (N = 2, 236) of women with breast cancer utilized traditional Chinese medicine (TCM) and 18% of them sought TCM with the intent of treating their breast cancer. Jia-wei-xiao-yao-san (Augmented Rambling Powder) was the most frequently prescribed formula for treating breast cancer. Among the top 10 most frequently prescribed CHP for treating breast cancer, seven contained dang qui (Angelica sinensis-radix) and six contained ren shen (Panax ginseng-radix), which are reported to have potential beneficial synergistic effects on breast cancer cells. Conclusion. CHP containing dang qui (Angelica sinensis-radix) or ren shen (Panax ginseng-radix) are the most frequently prescribed for breast cancer and their effects should be taken into account by healthcare providers. SN - 1741-4288 UR - https://www.unboundmedicine.com/medline/citation/22685488/Prescription_pattern_of_chinese_herbal_products_for_breast_cancer_in_taiwan:_a_population_based_study_ L2 - https://doi.org/10.1155/2012/891893 DB - PRIME DP - Unbound Medicine ER -